OPRK1 promoter hypermethylation increases the risk of Alzheimer’s disease
Huihui Ji(Wenzhou Medical University), Qinwen Wang(Ningbo University), Qingxiao Hong(Ningbo University), Xuting Xu(Huzhou Central Hospital), Pengyuan An(Ningbo University), Dongjun Dai(Ningbo University), Dongsheng Zhou(China General Nuclear Power Corporation (China)), Xiaohui Zhou(China Pharmaceutical University), Guili Liu(Ningbo University), Liyuan Han(Ningbo University), Yu Liu(Wuhan University), Ying Li(Affiliated Hospital of Southwest Medical University), Jinfeng Li(Hebei Medical University), Xiaonan Zhang(Yunnan University), Lei Xu(Ningbo University), Liting Jiang(Shanghai Jiao Tong University), Yunliang Wang(Beijing University of Chinese Medicine), Renjie Zhuo(Ningbo University), Zhongming Chen(South China Agricultural University), Lan Chang(Ningbo University), Shiwei Duan(Communication University of Zhejiang)
Cited by 34
Related Papers
Small-molecule conversion of toxic oligomers to nontoxic β-sheet–rich amyloid fibrils
|Nature Chemical Biology|2011|442
Germline Mutations in Cancer Susceptibility Genes in a Large Series of Unselected Breast Cancer Patients
|Clinical Cancer Research|2017|272
Triazole–Dithiocarbamate Based Selective Lysine Specific Demethylase 1 (LSD1) Inactivators Inhibit Gastric Cancer Cell Growth, Invasion, and Migration
|Journal of Medicinal Chemistry|2013|221
Expression of ER-α36, a Novel Variant of Estrogen Receptor α, and Resistance to Tamoxifen Treatment in Breast Cancer
|Journal of Clinical Oncology|2009|218